SNP type | Gene | Position, base change (AA change) | rsID (%MAF EA/AA/All) | Disease [prediction counts] | Grantham score | Protein stability change | Site annotations |
---|---|---|---|---|---|---|---|
Disease-causal | ATP6V0A4 | 7:138417791 | rs3807153* (4.8/18.5/9.4) | Distal renal tubular acidosis (dRTA) with preserved hearing | 81 | Neutral | TRANSMEM |
A-->G (M580T) | [Del count: 2; Con count: 3] | ||||||
MTMR2 | 11:95569448 | rs558018 (0.02/3.9/1.3) | Charcot-Marie-Tooth disease type 4B1 (CMT4B1) | 46 | Decrease | DOMAIN | |
T-->C (N545S) | [Del count: 2; Con count: 3] | ||||||
APOE | 19:45412079 | rs7412 (5.6/8.7/6.6) | Lipoprotein glomerulopathy (LPG) | 180 | Decrease | REPEAT | |
C-->T (R176C) | [Del count: 5; Con count: 3] | ||||||
BMP15 | X:50658966 | rs104894767 (1.4/0.3/1.0) | Premature ovarian failure type 4 (POF4) | 58 | Neutral | PROPEP | |
G-->A (A180T) | [Del count: 0; Con count: 1] | ||||||
Probable pathogenic | FRZB | 2:183699584 | rs7775 (8.8/28.4/15.4) | Osteoarthritis type 1 (OS1) | 125 | Neutral | - |
G-->C (R324G) | [Del count: 1; Con count: 3] | ||||||
HABP2 | 10:115348046 | rs7080536 (3.9/0.7/2.8) | [Del count: 5; Con count: 3] | 98 | Decrease | DOMAIN | |
G-->A (G534E) | |||||||
HNF1A | 12:121416650 | rs1169288 (33.5/12.1/26.2) | Insulin-dependent diabetes mellitus type 20 (IDDM20) | 5 | Neutral | REGION (Dimerization) | |
A-->C (I27L) | [Del count: 1; Con count: 3] | ||||||
XYLT1 | 16:17564311 | rs61758388 (-/-/1.7) | [Del count: 0; Con count: 3] | 99 | Neutral | TOPO_DOM | |
C-->A (A115S) | |||||||
CYP2A6 | 19:41354533 | rs1801272 (2.5/0.5/1.8) | [Del count: 1; Con count: 3] | 99 | Decrease | - | |
A-->T (L160H) | |||||||
ADA | 20:43255220 | rs11555566 (6.3/6.8/6.5) | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell- negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) | 26 | Decrease | - | |
T-->C (K80R) | |||||||
[Del count: 1; Con count: 3] |